Site-specific CpG methylation in the CCAAT/enhancer binding protein delta (CEBPδ) CpG island in breast cancer is associated with metastatic relapse.

MLA

Palmieri C, et al. “Site-Specific CpG Methylation in the CCAAT/Enhancer Binding Protein Delta (CEBPδ) CpG Island in Breast Cancer Is Associated with Metastatic Relapse.” British Journal of Cancer, vol. 107, no. 4, Aug. 2012, pp. 732–38. EBSCOhost, https://doi.org/10.1038/bjc.2012.308.

APA

Palmieri C, Monteverde M, Lattanzio L, Gojis O, Rudraraju B, Fortunato M, Syed N, Thompson A, Garrone O, Merlano M, Lo Nigro C, Crook T, Palmieri, C., Monteverde, M., Lattanzio, L., Gojis, O., Rudraraju, B., Fortunato, M., Syed, N., & Thompson, A. (2012). Site-specific CpG methylation in the CCAAT/enhancer binding protein delta (CEBPδ) CpG island in breast cancer is associated with metastatic relapse. British Journal of Cancer, 107(4), 732–738. https://doi.org/10.1038/bjc.2012.308

Chicago

Palmieri C, Monteverde M, Lattanzio L, Gojis O, Rudraraju B, Fortunato M, Syed N, et al. 2012. “Site-Specific CpG Methylation in the CCAAT/Enhancer Binding Protein Delta (CEBPδ) CpG Island in Breast Cancer Is Associated with Metastatic Relapse.” British Journal of Cancer 107 (4): 732–38. doi:10.1038/bjc.2012.308.